ProQR Therapeutics N.V. (PRQR)
$1.63+3.82%Close
SELLCRISIS · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $172M
- Beta
- 0.03
- P/E (TTM)
- -3.70
- Short % float
- 4.46%
- Days to cover
- 5.0
- SI change
- +19.2%
- 1W
- -0.61%
- 1M
- -15.98%
- vs SPY 1W
- -1.77%
- vs SPY 1M
- -18.97%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PRQR?
- LOPJLB’s latest quantitative signal on ProQR Therapeutics N.V. (PRQR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PRQR in?
- ProQR Therapeutics N.V. (PRQR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does ProQR Therapeutics N.V. (PRQR) do?
- ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently in a Phase II/III clinical trial, known as the ILLUMINATE trial, targeting Leber Congenital Amaurosis 10 (LCA10). Ulte…